Research
Education
Healthcare
Community
About
Researchers Explore the Genetics of Diabetes and Obesity with $7.8 Million NIH Award
What makes people genetically prone to diabetes and obesity? That is the central question of a new $7.8 million NIH grant for a multidisciplinary study co-led by Wei Li, PhD.
Meet the Incoming School of Medicine PhD Students – 2026
Meet the newest 39 members of the UCI School of Medicine graduate community joining the PhD in Biomedical Sciences program this fall. See about their backgrounds and research interests below.
UC Irvine School of Medicine's PhD Orientation 2026
UCI School of Medicine welcomes 35 incoming PhD students for the 2026-2027 academic year.
The Secret to Affordable Biomanufacturing: UC Irvine Researchers Find Nature’s Recipe
UC Irvine researchers have identified the “secret code” in nature that lets enzymes run on a cheap, widely available fuel, offering a new approach for dramatically reducing biomanufacturing costs.
High Fructose Consumption and the Unexpected Role of the Small Intestine
A UC Irvine study provides evidence that dietary sugar intake in the form of fructose is a key culprit affecting how the body — in particular, the small intestine — handles other nutrients like fat.
Cholsoon Jang, PhD, Receives 9th Hansung Science Award
As head of the Nutrient Metabolism & Disease Lab at UC Irvine, Cholsoon Jang, PhD, received the 9th Hansung Science Award for novel research into metabolic diseases and aging.
Newly Published Volume Contextualizes the Human Genome Project to Advance Precision Medicine
The groundbreaking volume Perspectives on the Human Genome Project and Genomics takes a look back at one of the greatest scientific feats in history, offering a roadmap for realizing the potential of precision medicine.
First Participant Dosed in Pioneering Neural Stem Cell Trial for Huntington's Disease
The study is being conducted at the University of California, Irvine through the UCI Alpha Clinic, with support from the California Institute for Regenerative Medicine (CIRM). The trial is led by Leslie Thompson, PhD, a long-time HD researcher.
Cancer Drug Combo Activates Inflammatory Signal That Could Boost Immune Response
"Our study revealed that a combination of cancer drugs can do more than damage cancer-cell DNA to kill the cancer cells," explains postdoctoral fellow Elodie Bournique, PhD. "They can also trigger an 'alarm signal' inside the cancer cells that alerts the body to their presence and recruits immune cells to help eliminate them."
Sounding the Alarm: A New Strategy in Cancer Therapy
A new study by UC Irvine researchers has identified a mechanism that could enhance both DNA damage and inflammatory signaling in tumor cells, potentially improving cancer treatment response.